86 related articles for article (PubMed ID: 2492446)
1. Nonionic contrast media: economic analysis and health policy development.
Goel V; Deber RB; Detsky AS
CMAJ; 1989 Feb; 140(4):389-95. PubMed ID: 2492446
[TBL] [Abstract][Full Text] [Related]
2. Indications for the use of low-osmolar contrast agents.
Bloom DM
Physician Exec; 1989; 15(4):24-5. PubMed ID: 10313370
[TBL] [Abstract][Full Text] [Related]
3. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of sevelamer in patients with end-stage renal disease.
Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
[TBL] [Abstract][Full Text] [Related]
5. Nonionic contrast agents: clinical and cost considerations.
Wolf G
Radiol Manage; 1986 Jul; 8(3):66-8. PubMed ID: 10311703
[No Abstract] [Full Text] [Related]
6. Cost-utility analysis of cataract surgery in the second eye.
Busbee BG; Brown MM; Brown GC; Sharma S
Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
[TBL] [Abstract][Full Text] [Related]
7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
8. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
[TBL] [Abstract][Full Text] [Related]
9. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
10. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
11. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease.
Klarenbach SW; Pannu N; Tonelli MA; Manns BJ
Crit Care Med; 2006 Apr; 34(4):1044-51. PubMed ID: 16484907
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.
Caro JJ; Trindade E; McGregor M
AJR Am J Roentgenol; 1992 Oct; 159(4):869-74. PubMed ID: 1529856
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.
Goeree R; Bowen JM; Blackhouse G; Lazzam C; Cohen E; Chiu M; Hopkins R; Tarride JE; Tu JV
Int J Technol Assess Health Care; 2009 Apr; 25(2):196-207. PubMed ID: 19331710
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit evaluation of body computed tomography.
Moore AT; Dixon AK; Rubenstein D; Wheeler T
Health Trends; 1987 Aug; 19(3):8-12. PubMed ID: 10312239
[TBL] [Abstract][Full Text] [Related]
16. Low-osmolality contrast media: good news or bad?
Evens RG
Radiology; 1988 Oct; 169(1):277-8. PubMed ID: 3138706
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery catheterization in exacerbations of COPD requiring mechanical ventilation: a cost-effectiveness analysis.
Smith KJ; Pesce RR
Respir Care; 1994 Oct; 39(10):961-7. PubMed ID: 10146114
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
20. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions.
Dalziel K; Segal L
Health Promot Int; 2007 Dec; 22(4):271-83. PubMed ID: 17916604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
